Patient portal
Intake, consents, labs in plain language, protocol and dose, secure messaging, wearable trends, store and checkout — on a phone, with no app store.
ARC is a clinical platform purpose-built for longevity and hormone optimization medicine — intake through lab interpretation, protocol design, pharmacy fulfillment, commerce and daily biometrics, in one record. Proven in production. Now packaged to sell.
Clinics in this category are opening faster than the tools built to run them. Most operate on a stack assembled from whatever was available — a scheduler here, a chart there, a payment page bolted on the side — none of it designed for the way this medicine is actually practised. The work splits across systems that don't talk, and the patient experience, which is the product, lives in the gaps between them. ARC is the layer that was missing.
ARC was built with and for Aspire Rejuvenation, a longevity and hormone optimization practice, and it carries their live operation today — real patients, real charts, real money moving through it. Every screen in this deck is the production build, not a mockup. That is the difference between a pitch and a product, and it is why the platform is ready to license to clinics that are not Aspire.
Patients get something that feels like a consumer health product. Clinicians get a dense, keyboard-fast chart. Both read and write the same record in real time — no export step, no second login, nothing to reconcile at month end.
Intake, consents, labs in plain language, protocol and dose, secure messaging, wearable trends, store and checkout — on a phone, with no app store.
Scheduling, charting, order entry, lab reconciliation, pharmacy routing, inventory and revenue — the whole patient timeline on one screen.
One record, one audit trail, one permission model. Every view is a projection of the same source of truth — which is what makes the platform licensable rather than a pile of features.
Guided intake collects history, symptoms and goals in short legible steps. Consents and HIPAA acknowledgements are signed inline. Everything lands structured in the chart — nothing gets retyped by staff.
Results arrive with optimal ranges, not just reference ranges, plotted against every prior draw. Hormone, thyroid, metabolic and inflammatory panels each get a plain-language read and a link to the protocol they informed.
Active therapies show current dose, schedule, refill status and the exact pharmacy the order went to. Reminders go by SMS and email, and a missed dose is visible to the care team before the next visit.
Plans, visits, labs and retail items are priced transparently and paid in-portal. Cards tokenize in the browser and never touch platform servers. Renewals, receipts and balances live with the rest of the record.
A real anatomical model sits at the centre of the record. Six systems toggle independently. Select an organ and the platform surfaces every lab value, symptom report, therapy and note attached to it — for patients an explanation, for clinicians a spatial index into the chart. Nothing else in this category has one.
Patients don't churn out of a plan they can see themselves inside of.PRODUCT THESIS · ARC
Schedule, room state, intake completion and outstanding balances on one board. Providers see who is ready, who is waiting on labs and who hasn't signed a consent — before the door opens.
Templated encounters for hormone optimization, peptides, weight management and aesthetics. Prior values, current protocol and trend lines sit beside the note instead of three clicks away.
Compounded and commercial orders are composed in-chart and routed to partner pharmacies with dose, quantity and refill logic already validated. Status flows back onto the patient timeline.
Memberships, visits, labs and product sales post against the same ledger as payments. Failed renewals, refunds and balances surface as work items, not as a month-end spreadsheet.
The platform is not one product with a single buyer. It decomposes into separately licensable assets — which is what turns a clinic build into a company.
The hardest part of selling clinical software is not the demo. It's the switch. ARC ships a public API with documentation, and a mass-import format that lifts a clinic off its legacy EMR without a manual re-key — so the thing standing between a signed contract and a live deployment is days, not quarters.
Documented, versioned endpoints over the clinical core, so partners, labs and third-party developers can build against ARC rather than around it.
A defined mass-import specification for bulk clinic migration — patients, charts, documents and history — turning the industry's biggest switching cost into an onboarding step.
A productized onboarding flow for new clinics — provisioning, branding, staff roles and configuration — so deployment is a process rather than a bespoke engagement.
The in-app Store module puts labs and prescription fulfillment where the clinical decision is already being made. Built against a pharmacy supplier's partner API and designed white-label from the outset, so a licensing clinic runs it under their own brand with their own margin — a recurring revenue line that arrives with the platform rather than being sold separately.
Ordering sits beside the protocol that triggered it, not in a separate vendor portal.
Branding, catalogue and pricing are per-tenant configuration, not a fork of the codebase.
Browser-side tokenization keeps the platform out of raw cardholder scope entirely.
Sleep, recovery, heart rate variability, weight and activity stream in from devices patients already wear. A quarterly blood draw becomes a continuous picture — and the strongest argument a clinic has for staying on protocol.
Filled markers are connected in the current build. Remaining integrations are credentialed and queued behind partner approval.
Protected health information is the platform's most valuable and most dangerous asset. The architecture treats it that way at every layer — storage, transport, access, retention and audit. For a licensee, this is not a feature list; it is the reason they can buy at all.
Nothing exotic in the critical path. Managed infrastructure, typed end to end, deployed continuously — so engineering time goes into clinical product rather than plumbing.
Scope is fixed per phase against written acceptance criteria and milestone payments, with formal sign-off before the next phase opens. No open-ended build, no drifting timeline.
A live walkthrough of the production build — the patient journey end to end, the clinical chart, the body map in motion, and the commercial surface underneath it.
Request a walkthrough